Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
18.23
-1.80 (-9.01%)
Jun 5, 2026, 2:34 PM EDT - Market open
Alto Neuroscience Employees
Alto Neuroscience had 68 employees as of December 31, 2025. The number of employees decreased by 8 or -10.53% compared to the previous year.
Employees
68
Change (1Y)
-8
Growth (1Y)
-10.53%
Revenue / Employee
n/a
Profits / Employee
-$1,092,735
Market Cap
638.84M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | -8 | -10.53% |
| Dec 31, 2024 | 76 | 9 | 13.43% |
| Sep 30, 2024 | 88 | 27 | 44.26% |
| Jun 30, 2024 | 78 | 17 | 27.87% |
| Mar 31, 2024 | 67 | - | - |
| Sep 30, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CorMedix | 191 |
| Omeros | 175 |
| Allogene Therapeutics | 152 |
| Solid Biosciences | 121 |
| CytomX Therapeutics | 69 |
| Oculis Holding AG | 60 |
| Candel Therapeutics | 55 |
| Design Therapeutics | 54 |
ANRO News
- 2 days ago - Alto Neuroscience Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 8 days ago - Alto Neuroscience appoints Miller to Board of Directors - TheFly
- 8 days ago - Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors - Business Wire
- 14 days ago - Alto Neuroscience price target lowered to $33 from $35 at BofA - TheFly
- 18 days ago - Alto Neuroscience price target lowered to $36 from $38 at Baird - TheFly
- 21 days ago - Alto Neuroscience CEO Amit Etkin, M.D., Ph.D. Receives Columbia University Transformational Research Award - Business Wire
- 22 days ago - Alto Neuroscience price target raised to $24 from $21 at Wedbush - TheFly
- 22 days ago - Alto Neuroscience Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts